This level of personalization increases the likelihood of sustainable weight loss and better metabolic health long-term
For many of them, that wait is over as we can now offer the powerful efficacy of Wegovy in a once-daily pill that demonstrated about 17% weight loss, if all patients stayed on treatment," said Ed Cinca, senior vice president, Marketing & Patient Solutions at Novo Nordisk
The patients who stand to benefit most from dramatic weight loss interventions are often those with the fewest resources to navigate a $1,200-per-month drug bill
Lachey, J
In contrast, Clinical trials have shown that on average, patients lost up to 22.5% of their original weight on the highest dose of Mounjaro (15mg) after 72 weeks
PlexusDx providers assess individual metabolic profiles to ensure semaglutide aligns with your specific weight-loss physiology